Skip to main content
. 2022 Feb 16:1–4. doi: 10.1017/S1049023X22000309

Table 1.

Significant Differences Between Respondents Who Declined a COVID-19 Vaccine Dose and Respondents Who Did Not

Parameter Respondents Who Declined a COVID-19 Vaccine Dose (n = 26) Respondents Who Did Not Decline a COVID-19 Vaccine Dose (n = 140) Significance
Male-Identifying (%) 85% 57% z = 2.6931, P < .01
Work in Rural Settings (%) 19% 6% z = 2.2393, P < .05
Self-Reported Conservative or Conservative-Leaning Beliefs (%) 77% 20% z = 5.8866, P < .01
Colleagues Spoke Negatively About Vaccine (%) 42% 8% z = 4.6848, P < .01
Colleagues Spoke Positively About Vaccine (%) 12% 67% z = −5.225, P < .01
Respondents’ Supervisor(s) Encouraged Vaccination (%) 31% 79% z = −4.9783, P < .01
Respondents’ Families Encouraged Vaccination (%) 19% 81% z = −6.4173, P < .01
Significant Concerns About Vaccine Safety (%) 73% 2% z = 9.8474, P < .01
Significant Concerns About Vaccine Effectiveness (%) 62% 9% z = 6.5612, P < .01
Significant Concerns About Speed of Vaccine Development (%) 73% 0.7% z = 10.4094, P < .01
Significant Concerns About Political Environment Surrounding Vaccines (%) 35% 0.7% z = 6.7254, P < .01
Significant Concerns About Government Involvement in Vaccine Development (%) 54% 13% z = 4.8532, P < .01

Abbreviation: COVID-19, coronavirus disease 2019.